What is AngioDynamics's gain on sale of business and assets?

AngioDynamics (ANGO) reported gain on sale of business and assets of $0 in Q1 2025.

How has AngioDynamics's gain on sale of business and assets changed year-over-year?

AngioDynamics's gain on sale of business and assets decreased by 100.0% year-over-year, from $13.62M to $0.

AngioDynamics ANGO Gain on sale of business and assets

Gain on sale of business and assets at other companies

Merit Medical SystemsMMSI

——

Other financials

Income statement

See full

Revenue$78.4M+8.9%

Gross profit$41.5M+6.7%

Operating income-$13.0M-29.8%

Net income-$8.1M-83.4%

EPS (diluted)-$0.19-72.7%

Balance sheet

See full

Cash & equivalents$37.8M-15.5%

Total debt$7.9M+10.2%

Total equity$173.4M-6.7%

Total assets$260.7M-8.7%

Cash flow

See full

Operating cash flow-$3.1M+76.4%

CapEx$1.0M-43.5%

Free cash flow-$4.1M+72.4%

Valuation

See full

Market cap$564.42M+38.7%

Enterprise value$534.51M+48.0%

P/S1.8×+0.4×

Profitability

See full

Gross margin54.3%-0.1pp

Operating margin-11.3%-2.9pp

Net margin-10%-2.4pp

FCF margin5.5%—

Returns & leverage

See full

Return on equity-17.5%-2.2pp

Debt / equity0×0.0×

Current ratio2.4×+0.1×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfBusiness.

The official record: AngioDynamics’s 10-K, filed July 18, 2025, on SEC EDGAR. View the filing →

Ask your AI about AngioDynamics's gain on sale of business and assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AngioDynamics's gain on sale of business and assets?: AngioDynamics (ANGO) reported gain on sale of business and assets of $0 in Q1 2025.
How has AngioDynamics's gain on sale of business and assets changed year-over-year?: AngioDynamics's gain on sale of business and assets decreased by 100.0% year-over-year, from $13.62M to $0.